Filing Details

Accession Number:
0001250853-14-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-29 21:34:56
Reporting Period:
2014-01-27
Filing Date:
2014-01-29
Accepted Time:
2014-01-29 21:34:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Galena Biopharma Inc. GALE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296543 J Mark Ahn 4640 S.w. Macadam Avenue, Suite 270
Portland OR 97239
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-27 50,000 $2.31 163,764 No 4 M Direct
Common Stock Acquisiton 2014-01-27 100,000 $1.38 263,764 No 4 M Direct
Common Stock Acquisiton 2014-01-27 324,890 $1.38 588,654 No 4 M Direct
Common Stock Acquisiton 2014-01-27 200,000 $0.72 788,654 No 4 M Direct
Common Stock Acquisiton 2014-01-27 121,875 $1.71 918,529 No 4 M Direct
Common Stock Disposition 2014-01-27 796,765 $4.83 113,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2014-01-27 50,000 $0.00 50,000 $2.31
Common Stock Stock Option Disposition 2014-01-27 100,000 $0.00 100,000 $1.38
Common Stock Stock Option Disposition 2014-01-27 324,890 $0.00 324,890 $1.38
Common Stock Stock Option Disposition 2014-01-27 200,000 $0.00 200,000 $0.72
Common Stock Stock Option Disposition 2014-01-27 121,875 $0.00 121,875 $1.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-01-13 No 4 M Direct
0 2011-03-31 2021-03-30 No 4 M Direct
25,110 2021-03-30 No 4 M Direct
200,000 2022-01-12 No 4 M Direct
423,173 2023-01-29 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $5.09 per share. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/13/11).
  3. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (3/31/11).
  4. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/12/12).
  5. The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/29/13).